63
Views
4
CrossRef citations to date
0
Altmetric
Review

Atypical antipsychotics in the treatment of bipolar disorder

, , &
Pages 751-760 | Published online: 02 Mar 2005

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Abhishek Chitnis, Rosa Wang, Shawn X. Sun, Shailja Dixit, Alie Tawah & Luke Boulanger. (2015) Impact of initiation of asenapine on patterns of utilization and cost of healthcare resources associated with the treatment of bipolar I disorder. Journal of Medical Economics 18:11, pages 863-870.
Read now

Articles from other publishers (3)

Monique D. Johnson, Sandra Haas Binford, Christina J. Ansted & Robert S. Kennedy. (2011) Meeting Highlights on Mood Disorders: The 3rd Annual Chair Summit. Health Outcomes Research in Medicine 2:3, pages e141-e155.
Crossref
Caleb M. Adler, David E. Fleck, Martin Brecher & Stephen M. Strakowski. (2007) Safety and tolerability of quetiapine in the treatment of acute mania in bipolar disorder. Journal of Affective Disorders 100, pages S15-S22.
Crossref
T D Gould, J A Quiroz, J Singh, C A ZarateJrJr & H K Manji. (2004) Emerging experimental therapeutics for bipolar disorder: insights from the molecular and cellular actions of current mood stabilizers. Molecular Psychiatry 9:8, pages 734-755.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.